Completed
Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma
NCT00397982
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +13 more
- Locations
-
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
- University of Virginia Cancer Center Charlottesville, Virginia, United States